MEDIAN Technologies

MEDIAN Technologies provides advanced medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. Since its inception, the company has developed a strong expertise in medical image processing. Based on industrial and research partnerships, and on its presence in more than 100 imaging departments of major cancer centers and health care institutions worldwide, the company provides innovative and enabling solutions for image interpretation and management, targeted to : the oncology clinical trials market the cancer patient care market The company currently has a staff of over 45 highly skilled individuals who are committed to the company’s mission of making a dramatic impact on cancer care and research. More than half of the staff works in R&D and service-related activities. The team includes different scientific and/or technical backgrounds and expertise in image processing, data management, project management, business development, regulatory compliance, and general corporate management.
Type
Public
HQ
Valbonne, FR
Founded
2002
Employees
54 (est)
MEDIAN Technologies was founded in 2002 and is headquartered in Valbonne, FR

MEDIAN Technologies Locations

Valbonne, FR
Cambridge, US

MEDIAN Technologies Metrics

MEDIAN Technologies Summary

Market capitalization

€106 M

Closing share price

€10.5
MEDIAN Technologies's latest market capitalization is €106 M.

MEDIAN Technologies Market Value History

MEDIAN Technologies News

MEDIAN Technologies Company Life

You may also be interested in